KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Cash (2016 - 2025)

Teladoc Health's Change in Cash history spans 12 years, with the latest figure at $54.5 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 6.5% year-over-year to $54.5 million; the TTM value through Dec 2025 reached -$523.3 million, down 394.09%, while the annual FY2025 figure was -$523.3 million, 394.09% down from the prior year.
  • Change in Cash for Q4 2025 was $54.5 million at Teladoc Health, up from $47.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $91.8 million in Q4 2023 and bottomed at -$518.2 million in Q2 2025.
  • The 5-year median for Change in Cash is $46.6 million (2022), against an average of $2.5 million.
  • The largest annual shift saw Change in Cash soared 472.36% in 2023 before it plummeted 900.43% in 2025.
  • A 5-year view of Change in Cash shows it stood at $69.8 million in 2021, then crashed by 77.01% to $16.0 million in 2022, then skyrocketed by 472.36% to $91.8 million in 2023, then plummeted by 36.48% to $58.3 million in 2024, then decreased by 6.5% to $54.5 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Change in Cash are $54.5 million (Q4 2025), $47.0 million (Q3 2025), and -$518.2 million (Q2 2025).